Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary vs intralesional eptifibatide administration in acute myocardial infarction
IRCT2016122722134N4Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3 trial of eptifibatide in myocardial infarction (MI) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Myocardial perfusion comparison. Started May 2016; status: completed.
02
Drugs
eptifibatide
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT2016122722134N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016122722134N4.